Cargando…
Managing Experimental 3D Structures in the Beyond‐Rule‐of‐5 Chemical Space: The Case of Rifampicin
The beyond‐Rule‐of‐5 (bRo5) chemical space is a source of new oral drugs and includes large and flexible compounds. Because of their size and conformational variability, bRo5 molecules assume different privileged conformations in the compartments of human body, i. e., they can exhibit chameleonic pr...
Autores principales: | Ermondi, Giuseppe, Lavore, Francesca, Vallaro, Maura, Tiana, Guido, Vasile, Francesca, Caron, Giulia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361677/ https://www.ncbi.nlm.nih.gov/pubmed/34114271 http://dx.doi.org/10.1002/chem.202100961 |
Ejemplares similares
-
Solubility prediction in the bRo5 chemical space: where are we right now?
por: Ermondi, Giuseppe, et al.
Publicado: (2020) -
Chamelogk:
A Chromatographic Chameleonicity Quantifier
to Design Orally Bioavailable Beyond-Rule-of-5 Drugs
por: Garcia Jimenez, Diego, et al.
Publicado: (2023) -
Refinement
of Computational Access to Molecular Physicochemical
Properties: From Ro5 to bRo5
por: Rossi Sebastiano, Matteo, et al.
Publicado: (2022) -
PROTACs and Building Blocks: The 2D Chemical Space in Very Early Drug Discovery
por: Ermondi, Giuseppe, et al.
Publicado: (2021) -
Designing Soluble
PROTACs: Strategies and Preliminary
Guidelines
por: García Jiménez, Diego, et al.
Publicado: (2022)